Últimas noticias sobre Impact BioMedical (AMEX:IBO) Bolsa

Impact BioMedical

Impact BioMedical Inc focuses on the advancement of drug discovery and prevention, inhibition, and treatment of neurological, oncological, and immune-related diseases. The Company is also developing open-air defense initiatives, which curb transmission of air-borne infectious diseases, such as tuberculosis and influenza.

Impact BioMedical Inc

International Bancshares Corporation - Common Stock

International Bancshares Corp

UNIVERSAL IBOGAINE INC by Universal Ibogaine Inc.

Universal Ibogaine Inc

INDUSTRIAL BK KOREA S/GDR by Industrial Bank of Korea

Industrial Bank of Korea

VanEck Robotics ETF

News

IPOs

Press Releases

Impact BioMedical Inc. Announces Pricing of Initial Public Offering

Biotech

General

DSS, Inc. Celebrates Impact BioMedical Inc.'s Successful IPO and Proudly Advances Shareholder Value

Impact BioMedical Inc. Announces the Closing of its Initial Public Offering

Management

Impact BioMedical Inc. Introduces Leadership Team to Drive Innovation and Growth

Legal

Impact BioMedical Inc. (NYSE: IBO) Announces 3F™ US Patent Issue

ALT5 Sigma

Anebulo Pharmaceuticals, Inc. - Common Stock

Anebulo Pharmaceuticals

AN2 Therapeutics

Athira Pharma

Aytu BioPharma

Qilian International Holding Group Ltd. - Class A Ordinary Shares

Qilian Intl Hldg Gr

CalciMedica

Cognition Therapeutics, Inc. - Common Stock

Cognition Therapeutics

Cocrystal Pharma

Cumberland Pharmaceuticals Inc. - Common Stock

Cumberland

Dare Bioscience

Durect

Eyenovia

IGC Pharma

Iterum Therapeutics

Lexaria Bioscience

Lipocine

MIRA Pharmaceuticals, Inc. - Common Stock

Mira Pharmaceuticals

NRX Pharmaceuticals

Ocuphire Pharma

ProPhase Labs

Reviva Pharmaceuticals Holdings, Inc. - Common Stock

Reviva Pharmaceuticals

Traws Pharma

TherapeuticsMD

VYNE Therapeutics

Comments

Impact BioMedical

Noticias

Últimas noticias sobre Impact BioMedical (AMEX:IBO) Bolsa

La gente también mira

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL